The most important advances in nephrology

Jürgen Floege

Jürgen Floege, MD, is a professor of medicine, director of the Division of Nephrology and Clinical Immunology at the University Hospital RWTH Aachen, Germany, and Distinguished Fellow of the European Renal Association – European Dialysis and Transplant Association (ERA-EDTA).

If you were to name the 3 most important recent advances in nephrology that are relevant for everyday practice, what would they be?

Very clearly, in nephrology, the discovery that sodium-glucose cotransporter-2 (SGLT-2) inhibitors work in every kind of chronic kidney disease is my number one choice.

The number two choice is less obvious, but it’s the long-term realization that blood pressure should not be low. It should be really low.

And number three I think is the recent discovery of mechanisms of diseases, which have given us totally new insights. And I think the most prominent example is membranous nephropathy where we now have a biomarker, that is, autoantibodies, which we use to guide our treatment. So we’re getting a little more into, let’s say, personalized medicine.

See also

We would love to hear from you

Comments, mistakes, suggestions?

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.